Meet with... National Cancer Institute
The Cove @ UC Irvine , 5141 California Ave. , Irvine , California 92617
October 12, 2016 from 12:30 PM to 15:00 PM (PST)
$10 - $35
The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center is coming to Irvine! Program Director Patti Weber will be presenting funding opportunities and other resources for startups in cancer technology. You will also learn about 15 new targeted funding opportunities in cancer detection, diagnosis and treatment in high priority areas of research for the NCI. Although the trends reflect improvements in cancer treatments and advances in technology have led to better tools for understanding, detecting and diagnosing cancer, we still have work to do. In 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States. The NCI is poised to reduce the burden of cancer in this country and around the world at an accelerated pace.
NCI PRESENTS CURRENT AND NEW FUNDING OPPORTUNITIES
Program Director Patti Weber will discuss the exciting new non-dilutive targeted funding opportunities in cancer focused technology development. She will explain the application and review process at the NIH to help small businesses submit stronger applications. Additionally, the presentation will cover other resources available at NCI SBIR such as the I-Corps at NIH Entrepreneurship Program and Investor Initiatives, designed to facilitate the success of SBIR companies.
Following the presentation, selected companies will have the opportunity to meet one-on-one with NCI. To be considered for a one-on-one meeting, please contact Patti Weber, by Friday, October 7th with your name, company name, and a short executive summary of your company as well as the technology project you would like to discuss with the NCI.
10:30 AM | Registration Opens, Networking
11:00 AM | Presentation and Q&A
11:45 AM | Networking Lunch
1:00 PM | Program Close
1:00-5:00 PM | One-on-one Meetings*
*Companies must have applied for a one-on-one meeting ahead of time and be approved. To be considered for a one-on-one meeting, please contact Patti Weber, by Friday, October 7th with your name, company name, and a short executive summary of your company as well as the technology project you would like to discuss with the NCI.
National Cancer Institute Participating Representative:
Patti Weber, DrPH | Program Director, SBIR Development Center, National Cancer Institute
Dr. Patricia Weber is a Program Director at the National Cancer Institute's Small Business Innovation Research (SBIR) Development Center. Dr Weber manages SBIR & STTR grants and contracts focused in the areas cancer prevention, digital health, and cancer therapeutics, including small molecule, immunotherapeutics, and biologics. In her role she provides oversight throughout the award period and mentors awardees in their technology goals and commercialization strategy. Dr Weber also plays an active role in a number of initiatives including the NCI Investor Forum, workshops and targeted funding initiatives. Prior to joining the SBIR Development Center she held various management level positions in research and development in both San Diego and Western Montana. She was Director of Microbiology and Immunology at a San Diego-based biotech company that focused on the discovery and development of peptide therapeutics. She then moved to western Montana where she was the Team Leader of Cardiovascular Pharmacology at Ribi ImmunoChem Research (currently GSK) in Hamilton, MT. In addition to managing the preclinical development efforts of an intravenous biological product for the prevention of ischemia/reperfusion injury associated with cardiopulmonary bypass procedures, she also worked on licensing the therapeutic to potential pharmaceutical partners. She joined the International Heart Institute of Montana in 2000 where she managed the Tissue Engineering and Surgical Research Laboratories. Her work involved the preclinical development of cardiovascular devices including heart valves, bioengineered blood vessels and novel, stent-based devices. Dr. Weber completed her Masters and Doctorate in Public Health with an emphasis in Biomedical Sciences at the School of Public Health, University of California at Berkeley.
Connect with Patti:
About the National Cancer Institute:
The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice. The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.
Connect with the NCI:
Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until October 11th (or sold out).
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time and be approved. To be considered for a one-on-one meeting, please contact Patti Weber, by Friday, October 7th with your name, company name, and a short executive summary of your company as well as the technology project you would like to discuss with the NCI.
About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.
The Cove @ UC Irvine
5141 California Ave. #200
Irvine, CA 92617